pharmaphorum

APRIL 13, 2022

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. Insulin rationing. In the US, approximately 37.3

Insulin 129

Insulin Drugs Production Hormones 129

The Pharma Data

SEPTEMBER 30, 2021

Lilly’s Insulin Lispro Injection, 100 units/mL — first introduced at half the list price of branded Humalog® (insulin lispro injection, 100 units/mL) in 2019 — will now have a 70 percent lower list price than Humalog U-100 starting January 1, 2022 Insulin Lispro Injection can be ordered through all U.S.

Insulin 52

Insulin Pharmacy Branding Medicine 52

XTalks

FEBRUARY 8, 2024

In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6 percent in the US, impacted by prior formulary losses as well as “erosion of the basal insulin market,” the company said in the statement. In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6

Sales 52

Sales Insulin FDA Approval Drugs 52

XTalks

JUNE 5, 2023

Semaglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, mimicking the GLP-1 hormone released in the gastrointestinal tract after eating. GLP-1 stimulates insulin production, thus reducing blood glucose levels, and it interacts with the brain to suppress appetite and create a feeling of fullness. mg and 2.4

FDA Approval 98

FDA Approval Containment Drugs Pharmacy 98

STAT News

DECEMBER 5, 2022

Mifepristone, a drug that blocks hormones necessary for pregnancy, was approved by the FDA in 2000. The PBMs then granted national formulary status based upon the highest price and upon which of the medicines generated the largest profits.

Insulin 52

Insulin Manufacturing Medicine Drugs 52

pharmaphorum

APRIL 1, 2022

Semglee (insulin glargine-yfgn) is the first biosimilar available at the retail pharmacy counter, and it obtained interchangeable status. And, manufacturers will likely pay close attention to the impact of Semglee’s interchangeable designation on the adoption of biosimilars in the retail pharmacy space.

Marketing 58

Marketing Pharmacy FDA Approval Manufacturing 58

pharmaphorum

OCTOBER 17, 2022

The new PenCycle programme covers Novo Nordisk’s FlexPen and FlexTouch devices, which are used to dispense insulin and other medications. ” The initiative was piloted at Boots pharmacies last year, but has now been taken to a national level, according to Novo Nordisk.

Pharmacy 63

Pharmacy Contamination Insulin Hormones 63